Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2022-09-15 Annual Report
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Annual Report 2021
Annual Report Classification · 1% confidence The document is titled 'Årsrapport 2021/22' (Annual Report 2021/22) for ChemoMetec. It contains comprehensive financial statements, management's review, auditor's report, and detailed operational data for the fiscal year. It is clearly a full annual report, not an announcement or a summary. FY 2021
2022-09-15 Danish
Annual Report 2021
Annual Report Classification · 1% confidence The document is titled 'Årsrapport 2021/22' (Annual Report 2021/22) for ChemoMetec. It contains comprehensive financial statements, management's review, auditor's report, and detailed operational data for the fiscal year. It is clearly a full annual report, not an announcement or a summary. FY 2021
2022-09-15 Danish
Årsrapport 2021/22 - Markant fremgang i udfordringernes skygge
Report Publication Announcement Classification · 1% confidence The document is an announcement (Announcement No. 229) that summarizes key financial highlights from the 2021/22 fiscal year and explicitly states that the full Annual Report is 'attached' and available for download via links. Following the 'Menu vs Meal' rule, this document is a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself. FY 2022
2022-09-15 Danish
Årsrapport 2021/22 - Markant fremgang i udfordringernes skygge
Annual Report Classification · 1% confidence The document is explicitly titled 'Extract from annual report 2021/22' and contains comprehensive financial data, including income statements, balance sheets, cash flow statements, and key financial ratios for the fiscal year. It also includes a CEO letter and management review. Although it is an 'extract', it contains substantive financial statements and analysis, fitting the definition of an Annual Report (10-K) or a comprehensive financial report. FY 2022
2022-09-15 English
Årsrapport 2021/22 - Markant fremgang i udfordringernes skygge
Report Publication Announcement Classification · 1% confidence The document is a short announcement (Meddelelse nr. 229) that summarizes key financial highlights from the 2021/22 annual report. It explicitly states 'Vedhæftet denne meddelelse' (Attached to this announcement) and provides links to download the actual annual report files. Following the 'Menu vs Meal' rule, this is a report publication announcement rather than the full annual report itself.
2022-09-15 Danish
Regulatory Filings 2022
Regulatory Filings Classification · 1% confidence The document is a formal announcement (MEDDELELSE NR. 228) dated September 14, 2022, providing forward-looking financial guidance (Forventninger til regnskabsåret 2022/23) for the upcoming fiscal year, including expected revenue and EBITDA. It also references the upcoming release of the 2021/22 Annual Report. Since this document is an official communication disclosing key financial expectations and operational updates outside of a standard periodic report (like 10-K or IR), and it is not a transcript, management discussion, or a simple dividend notice, it fits best under the general category for regulatory announcements or specific updates. Given that it is providing financial outlook/guidance, it is closely related to earnings information. However, it is not the formal Earnings Release (ER) itself, nor is it the full Annual Report (10-K). It is a specific notice regarding financial expectations. Since it is a formal, structured announcement that doesn't fit the highly specific categories like DIV, NAV, or DIRS, and it is not explicitly announcing the publication of a report (which would be RPA), the most appropriate general category for specific, non-standard regulatory disclosures is Regulatory Filings (RNS). The document length is short (2408 chars), but its content is substantive guidance, not just a pointer to another document.
2022-09-14 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.